INCOME TAXES - Tax Credits (Details) - USD ($) $ in Thousands |
Dec. 31, 2016 |
Dec. 31, 2015 |
|---|---|---|
| Tax credit carryforward | ||
| Orphan drug and research and development credits | $ 44,348 | $ 36,387 |
| Domestic country | Research | ||
| Tax credit carryforward | ||
| Amount of tax credit carryforward | 33,000 | |
| State jurisdiction | Research | ||
| Tax credit carryforward | ||
| Amount of tax credit carryforward | $ 25,700 |
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|